Pennel, Kathryn A. F. http://orcid.org/0000-0003-0186-1331
Hatthakarnkul, Phimmada
Wood, Colin S.
Lian, Guang-Yu
Al-Badran, Sara S. F.
Quinn, Jean A.
Legrini, Assya
Inthagard, Jitwadee
Alexander, Peter G.
van Wyk, Hester
Kurniawan, Ahmad
Hashmi, Umar
Gillespie, Michael A.
Mills, Megan
Ammar, Aula
Hay, Jennifer
Andersen, Ditte
Nixon, Colin
Rebus, Selma
Chang, David K.
Kelly, Caroline
Harkin, Andrea
Graham, Janet
Church, David
Tomlinson, Ian
Saunders, Mark
Iveson, Tim
Lannagan, Tamsin R. M.
Jackstadt, Rene
Maka, Noori
Horgan, Paul G.
Roxburgh, Campbell S. D.
Sansom, Owen J.
McMillan, Donald C.
Steele, Colin W.
Jamieson, Nigel B.
Park, James H.
Roseweir, Antonia K.
Edwards, Joanne
Funding for this research was provided by:
Chief Scientist Office (EPD/22/13)
Cancer Research UK (CRUK RRNPSF-JUL21/1D100010, CTRQQR-2021/100006, A26825, A21139, A31287, A28223, GEACC18004TAB, AIRC 22795)
Medical Research Council (MR/ R502327)
Article History
Received: 27 September 2023
Accepted: 16 January 2024
First Online: 1 March 2024
Declarations
:
: Ethical approval was in place for all patient samples utilised in the study.Cohort 1 (ethical approval WS/16/0207).Cohort 2 (TransSCOT Clinical Trial Cohort) (ethical approval 07/S0703/136 until 2019,16/WS/0207 2019 onwards). Cohort 3 (ethical approval MREC/01/0/36).
: All contributing authors agreed to the publication of this article.
: The authors declare no conflict of interests.